HearingAssist Eaze vs Lexie B3

The HearingAssist Eaze is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.4/5 in our lab testing. At $399, it positions itself as an affordable behind-the-ear option in the crowded OTC market, ranking #43 of 65 OTC hearing aids tested. In our testing, the Eaze showed mixed results across performance categories. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users can expect stable performance without whistling during typical daily activities. However, speech performance is a weakness: speech in quiet scored 2.6/5 (0.20 points below average) and speech in noise scored just 1.3/5 (also 0.20 points below average), which may limit benefit in challenging listening environments. The most significant limitation is music streaming, which scored 0.0/5—nearly 2 points below the category average of 1.92/5. Consumers who prioritize streaming audio from their phones should consider alternatives. Own-voice comfort also scored below average at 2.2/5, which may affect how natural users sound to themselves. At this price point, buyers have several higher-scoring alternatives to consider, including the Elehear Beyond (4.34/5) and Apple AirPods Pro 2 (4.04/5). The Eaze may suit budget-conscious consumers who prioritize feedback-free wear over streaming capability and don't frequently encounter noisy environments.

The Lexie B3 is a mid-priced OTC hearing aid available at $999 that achieves an A grade with a SoundScore of 4.7/5 in our lab testing, ranking #1 among 65 OTC hearing aid devices tested. This behind-the-ear style device delivers category-leading performance across multiple metrics. Speech clarity is a standout strength. In our lab testing, the Lexie B3 scores an excellent 4.5/5 for speech in quiet, measuring 1.73 points above the OTC category average. Speech in noise performance scores 2.5/5—above the category average by 1.02 points, though only mixed in absolute terms at 2.5/5. This pattern reflects the broader challenge OTC devices face in noisy environments while still positioning the B3 as a top performer relative to its category. Music streaming quality is solid at 3.3/5, outperforming the category average by 1.38 points. Own-voice comfort scores a solid 3.0/5, sitting 0.49 points above average. Feedback handling is excellent at 4.6/5, essentially matching the already-strong category average. The Lexie B3 is best suited for consumers seeking top-tier OTC sound performance without prescription hearing aid costs. Those who prioritize speech clarity in quieter settings will find particular value here. Budget-conscious shoppers may want to consider alternatives like the RxEars Rxi, which offers strong performance at a lower price point.